{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:45:27Z","timestamp":1793411127860,"version":"4.5.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To evaluate the prevalence and meaning of antineutrophil cytoplasmic antibodies (ANCA) positivity in a cohort of IgG4-related disease (IgG4-RD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We identified patients with ANCA determination from a retrospective cohort of 69 patients with IgG4-RD. ANCA were measured by indirect immunofluorescence microscopy (IIF) and\/or proteinase 3 (PR3)-ANCA and MPO-ANCA by ELISA. IIF patterns were classified as perinuclear (P-ANCA), cytoplasmic (C-ANCA) and atypical (X-ANCA). We compared the ANCA-positive vs the ANCA-negative IgG4-RD group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Out of 69 patients, 31 IgG4-RD patients had an ANCA determination. Four patients with concomitant systemic autoimmune diseases were excluded. We found positive ANCA by IIF in 14 (56%) of 25 patients tested. The most common IIF pattern was C-ANCA in eight (57.1%), followed by dual C-ANCA\/X-ANCA in four (28.6%) and P-ANCA and dual C-ANCA\/P-ANCA in one each (7.1%). Of the 20 patients with ANCA determination by both IIF and ELISA, four have positive ANCA by ELISA (three for MPO-ANCA and one for PR3-ANCA). Of the two patients with only ELISA determination, one was positive for MPO-ANCA. The prevalence of ANCA positivity by ELISA was 22.7% (5 out of 22 patients). ANCA was more frequent in the Mikulizc\/systemic phenotype (42.9%) compared with other phenotypes (P\u00a0=\u00a00.04). ANCA-positive IgG4-RD patients had more frequently lymph node and kidney involvement, high IgG1 levels and erythrocyte sedimentation rate, and positive antinuclear antibodies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>ANCA are found in a significant number of patients with IgG4-RD and differed from the ANCA-negative group in terms of clinical and serological features.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab124","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T15:12:05Z","timestamp":1612537925000},"page":"3845-3850","source":"Crossref","is-referenced-by-count":28,"title":["What is the meaning of ANCA positivity in IgG4-related disease?"],"prefix":"10.1093","volume":"60","author":[{"given":"Eduardo","family":"Mart\u00edn-Nares","sequence":"first","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7958-0391","authenticated-orcid":false,"given":"Gabriela","family":"Hernandez-Molina","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,6]]},"reference":[{"key":"2021080220013049700_keab124-B1","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/S2665-9913(19)30017-7","article-title":"Management of IgG4-related disease","volume":"1","author":"Zhang","year":"2019","journal-title":"Lancet Rheumatol"},{"key":"2021080220013049700_keab124-B2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","article-title":"Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts","volume":"78","author":"Wallace","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2021080220013049700_keab124-B3","doi-asserted-by":"crossref","first-page":"e4633","DOI":"10.1097\/MD.0000000000004633","article-title":"Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: a case report and review of the literature","volume":"95","author":"Della-Torre","year":"2016","journal-title":"Medicine"},{"key":"2021080220013049700_keab124-B4","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.autrev.2017.07.020","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome","volume":"16","author":"Danlos","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2021080220013049700_keab124-B5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10067-018-4212-1","article-title":"Prevalence of overlap of antineutrophil cytoplasmic antibody associated vasculitis with systemic autoimmune diseases: an unrecognized example of poliautoimmunity","volume":"38","author":"Mart\u00edn-Nares","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2021080220013049700_keab124-B6","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/art.39686","article-title":"IgG4-related disease: retrospective analysis of one hundred sixty-six patients","volume":"68","author":"Sekiguchi","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2021080220013049700_keab124-B7","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/1756-185X.13693","article-title":"Do ANCA-associated vasculitides and IgG4-related disease really overlap or not?","volume":"22","author":"Erden","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"2021080220013049700_keab124-B8","doi-asserted-by":"crossref","first-page":"e11641","DOI":"10.1097\/MD.0000000000011641","article-title":"Value of anti-plasminogen binding peptide, anti-carbonic anhydrase II, immunoglobulin G4, and other serological markers for the differentiation of autoimmune pancreatitis and pancreatic cancer","volume":"97","author":"Detlefsen","year":"2018","journal-title":"Medicine"},{"key":"2021080220013049700_keab124-B9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD)","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"key":"2021080220013049700_keab124-B10","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/acr.23543","article-title":"An International Multispecialty Validation Study of the IgG4-related disease responder index","volume":"70","author":"Wallace","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2021080220013049700_keab124-B11","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1515\/cclm-2017-0306","article-title":"An international survey on anti-neutrophil cytoplasmic antibodies (ANCA) testing in daily clinical practice","volume":"56","author":"Damoiseaux","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"2021080220013049700_keab124-B12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2249.2007.03453.x","article-title":"Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA)","volume":"150","author":"Talor","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"2021080220013049700_keab124-B13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0016-5085(00)70264-2","article-title":"Autoimmune-related pancreatitis is associated with autoantibodies and a Th1\/Th2-type cellular immune response","volume":"118","author":"Okazaki","year":"2000","journal-title":"Gastroenterology"},{"key":"2021080220013049700_keab124-B14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/01.mpa.0000226881.48204.fd","article-title":"Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis","volume":"33","author":"Asada","year":"2006","journal-title":"Pancreas"},{"key":"2021080220013049700_keab124-B15","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1007\/s10067-020-05135-y","article-title":"IgG4-related kidney disease: experience from a Mexican cohort","volume":"39","author":"Mart\u00edn-Nares","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2021080220013049700_keab124-B16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/art.41140","article-title":"Disease severity linked to increase in autoantibody diversity in IgG4-related disease","volume":"72","author":"Liu","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2021080220013049700_keab124-B17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2249.1991.tb05647.x","article-title":"Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders","volume":"83","author":"Brouwer","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"2021080220013049700_keab124-B18","doi-asserted-by":"crossref","first-page":"e226280","DOI":"10.1136\/bcr-2018-226280","article-title":"Granulomatosis with polyangiitis in a patient with biopsy-proven IgG4-related pulmonary disease and coincident small cell lung cancer","volume":"12","author":"Abbass","year":"2019","journal-title":"BMJ Case Rep"},{"key":"2021080220013049700_keab124-B19","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2215\/CJN.10411012","article-title":"Relation between asymptomatic proteinase 3 antibodies and future granulomatosis with polyangiitis","volume":"8","author":"Olson","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021080220013049700_keab124-B20","doi-asserted-by":"crossref","first-page":"e0199659","DOI":"10.1371\/journal.pone.0199659","article-title":"Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias","volume":"13","author":"Hozumi","year":"2018","journal-title":"PLoS One"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab124\/36540100\/keab124.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/8\/3845\/39543568\/keab124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/8\/3845\/39543568\/keab124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T20:21:52Z","timestamp":1627935712000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/8\/3845\/6129759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,6]]},"references-count":20,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,2,6]]},"published-print":{"date-parts":[[2021,8,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab124","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8,1]]},"published":{"date-parts":[[2021,2,6]]}}}